87 related articles for article (PubMed ID: 11787128)
1. [Promises, disappointments and possibilities of screening tests].
Saarelma O; Hakama M
Duodecim; 2000; 116(8):869-70. PubMed ID: 11787128
[No Abstract] [Full Text] [Related]
2. [Present status and problems of mass screening--from the viewpoint of public health].
Miyake K
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):515-9. PubMed ID: 3093347
[No Abstract] [Full Text] [Related]
3. [Screening of colorectal cancer in Finland and analysis of its cost-effectiveness].
Malila N; Anttila A; Elovainio L; Hakulinen T; Järvinen H; Paimela H; Pikkarainen P; Rautalahti M; Hakama M
Duodecim; 2003; 119(12):1115-23. PubMed ID: 12868357
[No Abstract] [Full Text] [Related]
4. [Routine health screening, yes or no? It depends].
Köck CM
Wien Klin Wochenschr; 1997 Mar; 109(5):141-4. PubMed ID: 9173661
[No Abstract] [Full Text] [Related]
5. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
[TBL] [Abstract][Full Text] [Related]
6. Screening for cervical cancer in the era of the HPV vaccine--the urgent need for both new screening guidelines and new biomarkers.
Kiviat NB; Hawes SE; Feng Q
J Natl Cancer Inst; 2008 Mar; 100(5):290-1. PubMed ID: 18314471
[No Abstract] [Full Text] [Related]
7. Screening for colorectal cancer: which test can we afford?
Lansdorp-Vogelaar I; van Ballegooijen M; Kuipers EJ
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S38-40. PubMed ID: 18368641
[No Abstract] [Full Text] [Related]
8. Developing and testing a cost-assessment tool for cancer screening programs.
Subramanian S; Ekwueme DU; Gardner JG; Trogdon J
Am J Prev Med; 2009 Sep; 37(3):242-7. PubMed ID: 19666160
[TBL] [Abstract][Full Text] [Related]
9. [Preventive medicine: costs and responsibilities of insurance companies].
Brunner HH
Praxis (Bern 1994); 1998 Jan; 87(3):57-60, 62-3. PubMed ID: 9492587
[TBL] [Abstract][Full Text] [Related]
10. [Screening for cancer still useful and effective].
Teppo L; Anttila A; Auvinen A; Hakama M
Duodecim; 2000; 116(8):893-901. PubMed ID: 11787133
[No Abstract] [Full Text] [Related]
11. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.
Kim JJ; Leung GM; Woo PP; Goldie SJ
J Public Health (Oxf); 2004 Jun; 26(2):130-7. PubMed ID: 15284314
[TBL] [Abstract][Full Text] [Related]
12. Doctors contest ACS screening advisory.
MPS; 1980 Jun; 11(6):3. PubMed ID: 10246944
[No Abstract] [Full Text] [Related]
13. [Differences in cervical cancer mass screening results in Greater-Helsinki area].
Nieminen P; Tarkkanen J; Timonen T; Meyer B; Hakama M; Anttila A
Duodecim; 2000; 116(22):2489-96. PubMed ID: 12053343
[No Abstract] [Full Text] [Related]
14. [Cost effectiveness of human papilloma virus testing in cervical cancer screening: a literature review].
Mejía A; Salas W
Biomedica; 2008 Mar; 28(1):160-72. PubMed ID: 18645671
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of organized screening in comparison to spontaneous Pap samples in the prevention of invasive cervical cancer].
Kallio M; Nieminen P; Anttila A; Hakama M
Duodecim; 2001; 117(14):1442-6. PubMed ID: 12181953
[No Abstract] [Full Text] [Related]
16. Free cancer screening for uninsured and underinsured women in Rhode Island.
DiPaolo B
Med Health R I; 2003 Sep; 86(9):287-8. PubMed ID: 14556414
[No Abstract] [Full Text] [Related]
17. Cytological screening for cervical cancer--what are its opportunity costs?
Bloch B; Denny L; Nevin J; Dehaeck K; Whittaker J; Soeters R
S Afr Med J; 1997 May; 87(5):615; author reply 615, 618. PubMed ID: 9254827
[No Abstract] [Full Text] [Related]
18. [Cervix cancer screening can be cost-effective. Combination of vaginal smears and the HPV test should be even more beneficial].
Bistoletti P; Ellström A; Dillner J; Sennfält K; Sparén P; Strander B
Lakartidningen; 2005 Jun 13-26; 102(24-25):1874-6, 1878-9. PubMed ID: 16044766
[No Abstract] [Full Text] [Related]
19. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
[TBL] [Abstract][Full Text] [Related]
20. [Screening of breast cancer].
Pamilo M
Duodecim; 2001; 117(19):1885-6. PubMed ID: 12181918
[No Abstract] [Full Text] [Related]
[Next] [New Search]
